Delivery Order SPE2DB20D3101-SPE2DB23FRPF8
Award Date 6/13/23
Potential Completion Date 6/14/23
Potential Value $6.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $3,936.44 and is a firm fixed price contract type. The ultimate completion date is June 26, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $71,709.80 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,915,634 units of the drug Pulmozyme, which is used for the treatment of cystic fibrosis. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $77,882.80 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of August 18, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- The U.S. government awarded a $20,963.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has no set-aside designation, is for the provision of Pulmozyme 1 mg/ml ampul 2.5 ml to the Department of Defense (DoD) and its Medical Supply Chain agency. Amerisourcebergen, a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop Support Medical for up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,689.45 fixed-price delivery order is for the supply of Pulmozyme 1 mg/mL ampules, a respiratory medication. The contract has an ultimate completion date of January 24, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $33,136.24 firm-fixed-price delivery order is for the supply of Pulmozyme 1 mg/mL ampuls (2.5 mL). The contract has an ultimate completion date of August 9, 2024 and does not utilize a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $20,964.92 and a completion date of May 27, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $5,736.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the prescription drug Pulmozyme (1 mg/ml ampul, 2.5 ml) and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml units) under a firm fixed-price contract with a ceiling value of $10,076.66. The order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) for the supply of Pulmozyme 1 mg/mL ampules. The contract is valued at $10,129.21 and has a firm fixed price pricing type. The place of performance is Conshohocken, Pennsylvania, and the ultimate completion date is September 25, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...